Phase 3 Uterine Fibroid Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
Uterine FibroidsMenorrhagia
JW Pharmaceutical254 enrolled1 locationNCT07378098
Recruiting
Phase 3
Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Heavy Menstrual BleedingUterine Fibroids
Qilu Pharmaceutical Co., Ltd.120 enrolled1 locationNCT06671548
Recruiting
Phase 3
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
EndometriosisUterine Fibroids
Sumitomo Pharma Switzerland GmbH1,000 enrolled120 locationsNCT05862272
Recruiting
Phase 2Phase 3
A Phase II/III Study of Efficacy and Safety of SHR7280 Tablets in Subjects With Menorrhagia With Uterine Fibroids
Uterine Fibroids With Menorrhagia
Jiangsu HengRui Medicine Co., Ltd.357 enrolled1 locationNCT05442827